Adult men with impaired glucose tolerance or recently diagnosed diabetes but no pathological hypogonadism who took 1,000 mg of testosterone undecanoate and underwent a lifestyle program from WW for two years had a lower risk for type 2 diabetes, compared with those who took placebo and participated in the lifestyle program, according to a study in The Lancet Diabetes & Endocrinology. Men in the testosterone therapy group had bigger declines in waist circumference, total fat mass, abdominal fat mass and fasting glucose, while those treated with placebo had a decrease in total muscle mass, arm muscle mass and hand-grip strength.
Testosterone therapy may cut T2D risk in adult men
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.